AVTR
Avantor Inc.
NYSE · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B | 6.39B | 6.04B | 5.86B | 1.25B |
| Cost of Revenue | — | — | — | — | — | — | — | — | — |
| Gross Profit | 2.14B | 2.28B | 2.36B | 2.60B | 2.50B | 2.08B | 1.92B | 1.82B | 432.8M |
| Operating Expenses | |||||||||
| R&D Expenses | — | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — | — |
| Total Op. Expenses | — | — | — | — | — | — | — | — | — |
| Operating Income | -246.2M | 1.08B | 696.4M | 1.13B | 972.2M | 706.8M | 551.8M | 413.5M | -210.4M |
| EBITDA | — | — | — | — | — | — | — | — | — |
| Below the Line | |||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — |
| Pre-Tax Income | — | — | — | — | — | — | — | — | — |
| Income Tax | — | — | — | — | — | — | — | — | — |
| Net Income | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M | 37.8M | -86.9M | -112.7M |
| Per Share | |||||||||
| EPS (basic) | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | — | — | — | — | — | — | — | — |
| Shares | |||||||||
| Basic Shares | — | — | — | — | — | — | — | — | — |
| Diluted Shares | 681M | 682M | 678M | 679M | 600M | 583M | 401M | 133M | — |